产品标题 产品货号 产品规格 厂家
Rhbdl1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5147541 kitORIGENE TECHNOLOGIES
Human pre-B lymphocyte 3 (VPREB3) from ORIGENE TECHNOLOGIESTP30466220 ugORIGENE TECHNOLOGIES
Human preferentially expressed antigen in melanoma (PRAME), transcript variant 4 from ORIGENE TECHNOLOGIESTP30787420 ugORIGENE TECHNOLOGIES
Human preferentially expressed antigen in melanoma (PRAME), transcript variant 3 from ORIGENE TECHNOLOGIESTP76046450 ugORIGENE TECHNOLOGIES
Human preferentially expressed antigen in melanoma (PRAME), transcript variant 5, full length from ORIGENE TECHNOLOGIESTP76091350 ugORIGENE TECHNOLOGIES
Human prefoldin subunit 1 (PFDN1) from ORIGENE TECHNOLOGIESTP30058420 ugORIGENE TECHNOLOGIES
Human prefoldin subunit 2 (PFDN2) from ORIGENE TECHNOLOGIESTP72022710 ugORIGENE TECHNOLOGIES
Human prefoldin subunit 4 (PFDN4) from ORIGENE TECHNOLOGIESTP30313720 ugORIGENE TECHNOLOGIES
Human prefoldin subunit 2 (PFDN2) from ORIGENE TECHNOLOGIESTP30455320 ugORIGENE TECHNOLOGIES
Human prefoldin subunit 6 (PFDN6) from ORIGENE TECHNOLOGIESTP30790120 ugORIGENE TECHNOLOGIES
Human prefoldin subunit 4 (PFDN4) from ORIGENE TECHNOLOGIESTP72051610 ugORIGENE TECHNOLOGIES
Human uridine phosphorylase 1 (UPP1), transcript variant 1 from ORIGENE TECHNOLOGIESTP30040620 ugORIGENE TECHNOLOGIES
Human uridine phosphorylase 1 (UPP1), transcript variant 2 from ORIGENE TECHNOLOGIESTP31912520 ugORIGENE TECHNOLOGIES
Human uridine phosphorylase 2 (UPP2), transcript variant 1 from ORIGENE TECHNOLOGIESTP30726020 ugORIGENE TECHNOLOGIES
Human uridine phosphorylase 1 (UPP1), transcript variant 1 from ORIGENE TECHNOLOGIESTP72092610 ugORIGENE TECHNOLOGIES
Human Urinary bladder; Adenocarcinoma of bladder, mucinous from ORIGENE TECHNOLOGIESCS5452745x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Adenocarcinoma of bladder, metastatic from ORIGENE TECHNOLOGIESCS7134375x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma in situ of bladder from ORIGENE TECHNOLOGIESCS8134555x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma in situ of bladder from ORIGENE TECHNOLOGIESCS6512245x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma in situ of bladder, transitional cell from ORIGENE TECHNOLOGIESCS7054845x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma in situ of urothelium from ORIGENE TECHNOLOGIESCS5530245x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, papillary transitional cell from ORIGENE TECHNOLOGIESCS5246185x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, papillary transitional cell from ORIGENE TECHNOLOGIESCS5012715x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, papillary transitional cell from ORIGENE TECHNOLOGIESCS6235555x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, papillary transitional cell from ORIGENE TECHNOLOGIESCS6444595x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, squamous cell from ORIGENE TECHNOLOGIESCS5573995x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, small cell, metastatic from ORIGENE TECHNOLOGIESCS5132655x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, papillary transitional cell from ORIGENE TECHNOLOGIESCS5396875x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS8133405x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS8111005x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS5209145x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS5053825x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS5449705x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS5481065x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS6022695x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS6012615x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS6237085x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS6257015x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS6224695x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS6317145x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS6377935x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS6396535x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS6459165x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS6484125x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell from ORIGENE TECHNOLOGIESCS8151265x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell, metastatic from ORIGENE TECHNOLOGIESCS5095695x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell, metastatic from ORIGENE TECHNOLOGIESCS5318535x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell, metastatic from ORIGENE TECHNOLOGIESCS5319175x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell, metastatic from ORIGENE TECHNOLOGIESCS6508875x5umORIGENE TECHNOLOGIES
Human Urinary bladder; Carcinoma of bladder, transitional cell (protein lysate) from ORIGENE TECHNOLOGIESCP565547150 ugORIGENE TECHNOLOGIES
 |< < 5590 5591 5592 5593 5594 5595 5596 5597 5598 > >| 第 5595/6274 页